HomeHealth

Health

$IASO Bio Presented the Outcomes of Relapsed/Refractory Multiple Myeloma (R/RMM) Patients with Renal Impairment Treated with Equecabtagene Autoleucel (Fucaso™) at 2024 IMS Annual Meeting$

Health

IASO Bio Presented the Outcomes of Relapsed/Refractory Multiple Myeloma (R/RMM) Patients with Renal Impairment Treated with Equecabtagene Autoleucel (Fucaso™) at 2024 IMS Annual Meeting

September 27, 2024

Health

Respected Lansing Hematologist Joins Karmanos Cancer Institute Detroit Team

September 26, 2024

Health

CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight

September 26, 2024

Health

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry

September 26, 2024

Health

New Research from the International Coaching Federation Highlights Trends in Workplace Burnout

September 25, 2024

Health

Sanofi: Poland’s EU Presidency – Paving the Way for a Competitive Pharmaceutical Industry

September 25, 2024

Health

New American Lung Association RSV Campaign Targets High-Risk Groups Amid Low Vaccination Rates

September 25, 2024

Health

FARMACEUTICALRX of Pennsylvania Announces Receipt of Formal Organic Marijuana Certification from Organic Accreditor Certified Kind

September 25, 2024

Health

Belief BioMed to Collaborate with AskBio to Explore the Potential of New Gene Therapies

September 25, 2024

Health

Dormez-vous Celebrates 30 Years of Expertise, Revealing New Insights on Evolving Sleep Trends

September 24, 2024

« 1 … 23 24 25 26 27 … 127 »

PressReach

SEARCH FOR AN ARTICLE

PressReach

Health

IASO Bio Presented the Outcomes of Relapsed/Refractory Multiple Myeloma (R/RMM) Patients with Renal Impairment Treated with Equecabtagene Autoleucel (Fucaso™) at 2024 IMS Annual Meeting

Respected Lansing Hematologist Joins Karmanos Cancer Institute Detroit Team

CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry

New Research from the International Coaching Federation Highlights Trends in Workplace Burnout

Sanofi: Poland’s EU Presidency – Paving the Way for a Competitive Pharmaceutical Industry

New American Lung Association RSV Campaign Targets High-Risk Groups Amid Low Vaccination Rates

FARMACEUTICALRX of Pennsylvania Announces Receipt of Formal Organic Marijuana Certification from Organic Accreditor Certified Kind

Belief BioMed to Collaborate with AskBio to Explore the Potential of New Gene Therapies

Dormez-vous Celebrates 30 Years of Expertise, Revealing New Insights on Evolving Sleep Trends

LATEST NEWS